Specialty pharmacy benefit — both Ionis products are self-injected, specialty-only
Back to payer list
60 patients today
2 updatesJun 1, 2026 May 18, 2026
Blue Cross Blue Shield Association · PBM: Prime Therapeutics · Iowa / South Dakota
Wellmark BCBS
Published Tryngolza pharmacy policy with 6-month initial authorization.
Commercial
Live from the coverage database
Policy Posture and UM Criteria by Indication
| INDICATION | STATUS | PUBLISHED CRITERIA | AUTH DURATION | EFFECTIVE | SOURCE | CONFIDENCE |
|---|---|---|---|---|---|---|
| Tryngolza (FCS) | Published — Restricted | Initial authorization of 6 months for FCS. Considered not medically necessary if criteria unmet. Manufacturer financial assistance program participation referenced as part of initial approval process. | 6 months | 2025-01-01 | Tryngolza Pharmacy Policy | Sourced |
Coverage Update YTD
2Across all sources
Treated Lives — Tryngolza (FCS)
60Patients on therapy
Ionis Brands Published
1 / 3Have a policy
Pending Policy Changes
1Next 30 days
Months since launch · illustrative
Treated Lives on Therapy — Tryngolza (FCS)
M1 · 5M4 · 14M8 · 27M12 · 40M18 · 51M24 · 60
50-state distribution · illustrative
Treated Lives by State — Tryngolza (FCS)
Fewer patientsMore patients
OR high
AI SUMMARY
Tryngolza — FCS Coverage Source Summary
Regional Blue with a published FCS policy requiring genetic or biochemical confirmation and lipidologist attestation.
Historical coverage trend
Tryngolza — FCS Lives Coverage Trend
% of lives by access status across historical snapshots.
CoveredPreferredNot coveredUnknown
Covered
80%+68 pts
Preferred
67%+62 pts
Not covered
8%-12 pts
Unknown
28%+24 pts
Latest source details
Tryngolza — FCS Coverage Details
3 source views
| Source | Payment Type | Policy Status | Latest Detail |
|---|---|---|---|
| MMIT Searchlight | Commercial | Published — Restricted | Syndicated data reflects the most recent policy language for this indication. |
| FRM submission | Medicare | Limited visibility | Field team confirms account-level nuance not yet captured in syndicated sources. |
| Market Access submission | Medicaid | Limited visibility | State/plan-level detail requires validation against current directories. |
Brand-specific feed
Latest Updates
MMIT Searchlight
Latest source refresh confirms no material change to published criteria this cycle.
FRM submission
Field notes on account-level access nuance submitted for validation.
Brand documents
Shared Documents
PDF, DOC, PNG or JPG · max 20 MB
Policy PDF
Uploaded by Market Access Team
Latest updated: Jun 1, 2026